Pediatric Allergy/Immunology Associates, Dallas, TX Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2002
NCT00157079
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now